Advance Search
XU Haixia, ZHU Chunlan, ZHANG Zunsheng, XIA Yidong, ZHANG Yu. Impact of Yougui Pill combined with modified Erchen Decoction in treating polycystic ovary syndrome[J]. Journal of Clinical Medicine in Practice, 2021, 25(10): 107-111, 115. DOI: 10.7619/jcmp.20210056
Citation: XU Haixia, ZHU Chunlan, ZHANG Zunsheng, XIA Yidong, ZHANG Yu. Impact of Yougui Pill combined with modified Erchen Decoction in treating polycystic ovary syndrome[J]. Journal of Clinical Medicine in Practice, 2021, 25(10): 107-111, 115. DOI: 10.7619/jcmp.20210056
shu

Impact of Yougui Pill combined with modified Erchen Decoction in treating polycystic ovary syndrome

  • 1.

    Department of Gynecology, The Seventh People's Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 200137

  • 2.

    Department of Gynecology, Shanghai Hospital of Traditional Chinese Medicine, Shanghai, 200071

More Information
  • Received Date: January 03, 2021
  • Available Online: June 01, 2021
  • Published Date: May 27, 2021
    Graphical Abstract
    • Abstract
  •   Objective  To observe the efficacy of Yougui Pill combined with modified Erchen Decoction in treating patients with polycystic ovary syndrome (PCOS), and its impact on serum angiopoietin-like protein (Angptl)-2, Angptl-4 and soluble fms-like tyrosine kinase receptor (sFlt)-1.
      Methods  A total of 92 PCOS patients were divided into observation group and control group according to the random numerical method, with 46 cases in each group. The control group was treated with conventional western medicine, and the observation group was treated with Yougui Pill combined with modified Erchen Decoction on the basis of the control group. The efficacy and incidence of adverse reactions were compared between the two groups and the acne score, cervical mucus score, ovarian volume, follicle number, estradiol, luteinizing hormone, follicle stimulating hormone, prolactin, resistance index (RI), pulsatility index (PI), mean blood flow velocity (Vm), Angptl-2, Angptl-4 and sFlt-1 levels were compared in two groups before and after treatment.
      Results  The total effective rate in observation group was 95.65%, which was significantly higher than 78.26% in control group (P < 0.05). The incidence of adverse reactions in the observation group was 4.35%, which was significantly lower than 19.57% in the control group (P < 0.05). After treatment, the acne score, RI, PI, Vm, estradiol, luteinizing hormone, follicle stimulating hormone, prolactin, Angptl-2 and sFlt-1 levels of two groups were lower than treatment before, and were lower in the observation group than those in the control group(P < 0.01). After treatment, the ovarian volume in the two groups was smaller, and the number of follicles was less than that before treatment(P < 0.01). The ovarian volume was smaller and the number of follicles in the observation group was less than those in the control(P < 0.01). After treatment, the cervical mucus score and the level of Angptl-4 in the two groups were higher than before treatment, and the observation group was significantly higher than the control group (P < 0.01).
      Conclusion  Yougui Pill combined with modified Erchen Decoction in the treatment of polycystic ovary syndrome is obvious, which can significantly improve symptoms, reduce hormone levels and improve uterine blood circulation. The action mechanism may be related to the reduction of serum Angptl-2, Angptl-4 and sFlt-1 levels.
    • FullText(HTML)
    • References (15)
  • [1]
    ESCOBAR-MORREALE H F. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment[J]. Nat Rev Endocrinol, 2018, 14(5): 270-284. doi: 10.1038/nrendo.2018.24
    [2]
    LIZNEVA D, SUTURINA L, WALKER W, et al. Criteria, prevalence, and phenotypes of polycystic ovary syndrome[J]. Fertil Steril, 2016, 106(1): 6-15. doi: 10.1016/j.fertnstert.2016.05.003
    [3]
    VATANNEJAD A, SALIMI F, MORADI N, et al. Evaluation of angiopoietin-like protein 3(ANGPTL3) levels in polycystic ovary syndrome[J]. Life Sci, 2020, 263: 118595. doi: 10.1016/j.lfs.2020.118595
    [4]
    LIU Z, LIU C, HAO C, et al. Aberrant expression of angiopoietin-like proteins 1 and 2 in cumulus cells is potentially associated with impaired oocyte developmental competence in polycystic ovary syndrome[J]. Gynecol Endocrinol, 2016, 32(7): 557-561. doi: 10.3109/09513590.2016.1138463
    [5]
    崔琳琳, 陈子江. 多囊卵巢综合征诊断标准和诊疗指南介绍[J]. 国际生殖健康/计划生育杂志, 2011, 30(5): 405-408. doi: 10.3969/j.issn.1674-1889.2011.05.018
    [6]
    刘宏奇. 中医妇科学[M]. 第2版. 北京: 科学出版社, 2011: 181-185.
    [7]
    刘艳, 段育华. 达英-35联合补肾化痰调经汤治疗肾虚痰湿型多囊卵巢综合征致月经后期[J]. 实用妇科内分泌电子杂志, 2019, 6(21): 72-73. https://www.cnki.com.cn/Article/CJFDTOTAL-FKDZ201921052.htm
    [8]
    刘成丽, 王丽丽, 曲凤占, 等. 右归丸联合小檗碱对多囊卵巢综合征胰岛素抵抗的研究[J]. 现代生物医学进展, 2015, 15(20): 3943-3945. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX201520040.htm
    [9]
    姚国晋, 孔立红, 杨柳, 等. 不同频率电针联合右归丸加减治疗肾虚型多囊卵巢综合征临床观察及对性激素、体质量指数的影响[J]. 河北中医, 2017, 39(7): 1005-1010. doi: 10.3969/j.issn.1002-2619.2017.07.011
    [10]
    Rahmani E, Akbarzadeh S, Broomand A, et al. Serum levels of angiopoietin-like protein 2 and obestatin in iranian women with polycystic ovary syndrome and normal body mass index[J]. J Clin Med, 2018, 7(7): 188-195. http://europepmc.org/abstract/MED/29932432
    [11]
    OSUMI H, HORIGUCHI H, KADOMATSU T, et al. Tumor cell-derived angiopoietin-like protein 2 establishes a preference for glycolytic metabolism in lung cancer cells[J]. Cancer Sci, 2020, 111(4): 1241-1253. doi: 10.1111/cas.14337
    [12]
    JUNG C H, LEE W J, LEE M J, et al. Association of serum angiopoietin-like protein 2 with carotid intima-media thickness in subjects with type 2 diabetes[J]. Cardiovasc Diabetol, 2015, 14(1): 1-8. doi: 10.1186/s12933-014-0162-3
    [13]
    GÜNEŞM, BUKAN N. Examination of angiopoietin-like protein 4, neuropeptide Y, omentin-1 levels of obese and non-obese patients with polycystic ovary syndrome[J]. Gynecol Endocrinol, 2015, 31(11): 903-906. http://www.ncbi.nlm.nih.gov/pubmed/26291814
    [14]
    CINKAJZLOVA A, MRAZ M, LACINOVA Z, et al. Angiopoietin-like protein 3 and 4 in obesity, type 2 diabetes mellitus, and malnutrition: the effect of weight reduction and realimentation[J]. Nutr Diabetes, 2018, 8(1): 21. doi: 10.1038/s41387-018-0032-2
    [15]
    MCCULLOCH L J, BRAMWELL L R, KNIGHT B, et al. Circulating and tissue specific transcription of angiopoietin-like protein 4 in human Type 2 diabetes[J]. Metabolism, 2020, 106: 154192. doi: 10.1016/j.metabol.2020.154192
    • Related Articles

  • Related Articles

    [1]SUN Ling, LI Tantan, WU Xifeng, MEN Lijie, JIA Meiyan, LU Jun. Correlations of serum tissue inhibitor of metalloproteinases-1, matrix metalloproteinase-9 and vascular endothelial growth factor with degree of myelofibrosis in patients with myeloproliferative neoplasms[J]. Journal of Clinical Medicine in Practice, 2024, 28(11): 34-40. DOI: 10.7619/jcmp.20234037
    [2]ZHANG Linyuan, ZHANG Jinbo, TAO Yongming, CHANG Yanjun, LIU Weikai. Effects of growth hormone on in vitro fertilization-embryo transfer in patients with polycystic ovary syndrome[J]. Journal of Clinical Medicine in Practice, 2023, 27(4): 48-51. DOI: 10.7619/jcmp.20222139
    [3]WANG Baoliang, ZHANG Ling, CHEN Tieliang, WU Jiajian, YANG Liqun, DONG Zhigang. Relationships of high mobility protein group 1 with vascular endothelial growth factor and microvessel density in colorectal cancer[J]. Journal of Clinical Medicine in Practice, 2022, 26(21): 80-84, 89. DOI: 10.7619/jcmp.20220808
    [4]LI Fengxia, WANG Yanshuo, SHI Yanxiang, LIU Linlin, FENG Yuhuan. Effect of vitamin E combined with metformin in infertility patients with polycystic ovary syndrome[J]. Journal of Clinical Medicine in Practice, 2022, 26(14): 97-100, 104. DOI: 10.7619/jcmp.20220640
    [5]HUANG Yanyan, LIN Shudian, ZHAN Feng, XIAO Lu, ZHAN Yuwei, MO Biyao, HAN Yeguang. Relationships of expressions of soluble programmed death receptor-1 and interferon regulatory factor 4 with disease activity and immunoinflammation of patients with rheumatoid arthritis[J]. Journal of Clinical Medicine in Practice, 2022, 26(11): 118-121, 137. DOI: 10.7619/jcmp.20214386
    [6]MING Ni, LIU Zhi, WU Haihui, ZHANG Guigui, LIU Lihua. Expression and significance of serum interferon-γ, serum amyloid A protein and soluble fms-like tyrosine kinase-1 in patients with unexplained recurrent spontaneous abortion[J]. Journal of Clinical Medicine in Practice, 2022, 26(9): 25-28. DOI: 10.7619/jcmp.20220861
    [7]HOU Baozhou, LI Huiping, WEI Sichen, MU Zongwei, LI Lijuan, TIAN Shuying. Clinical significance of serum vascular endothelial growth factor, soluble thymidine kinase-1 and T lymphocyte subsets in patients with primary hepatocellular carcinoma[J]. Journal of Clinical Medicine in Practice, 2022, 26(7): 98-102. DOI: 10.7619/jcmp.20214756
    [8]PU Zhiqiang, MAI Chao, MOU Tianyi, ZENG Jianhui. Relationships between serum high mobility group protein B1, soluble triggering receptor expressed on myeloid cells-like transcript 1 and acute lung injury induced by sepsis[J]. Journal of Clinical Medicine in Practice, 2021, 25(24): 97-100. DOI: 10.7619/jcmp.20212361
    [9]CAI Yifei, SUN Lizhou. Correlation between tissue factor, tissue factor pathway inhibitor and sFlt-1 in patients with preeclampsia[J]. Journal of Clinical Medicine in Practice, 2016, (15): 71-75. DOI: 10.7619/jcmp.201615020
    [10]TIAN Xiaohui, HU Bin, QIN Rong, WANG Han, MENG Xiangjun. Clinical significance of IGF-1 level and VEGF expression in diagnosis and treatment of patients with colon cancer[J]. Journal of Clinical Medicine in Practice, 2014, (3): 9-11. DOI: 10.7619/jcmp.201403003

  • Cited by

    Periodical cited type(2)

    1. 吴瑞英，王磊，杨知山，杨顶权. 雄激素性秃发的治疗进展. 武汉大学学报(医学版). 2023(01): 29-35 .
    2. 夏继宁，项晶. 透骨草-侧柏叶煎剂治疗雄激素性秃发的疗效及对患者焦虑与抑郁水平的影响. 中华全科医学. 2023(01): 123-126 .

    Other cited types(4)

Catalog

    Get Citation
    PDF
    XML
    Article views (409) PDF downloads (15) Cited by(6)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return